Global Compounding Pharmacy Market

Compounding Pharmacy Market Size, Share, Growth Analysis, By Product(Medications, Topical medications, Suppositories, Mouthwashes), By Therapeutic Area(Hormone replacement therapies, Pain medications, Dermatological applications), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2094 | Region: Global | Published Date: April, 2024
Pages: 157 | Tables: 64 | Figures: 75

Compounding Pharmacy Market Dynamics

Compounding Pharmacy Market Driver

  • Increased oral medication use is major opportunities for market expansion.

The oral market is anticipated to increase at a CAGR of over 6% through 2028, driven by the rising popularity of oral pharmaceuticals including tablets and capsules. Additionally, the majority of disorders can only be effectively treated by taking pharmaceuticals orally, which increases the demand for oral medications.

  • Compound pharmaceuticals are increasingly in demand due to the aging population, age-related chronic diseases, and rising health care costs. In order to avoid allergies that may otherwise be brought on by commercially accessible medicine formulations, patients are looking for compounded pharmacies to obtain pharmaceuticals with alternate dosages, customized routes of administration, and alternative ingredients. These elements have helped the market for compounding pharmacies in grow.

Compounding Pharmacy Market Restraint

  • The sales potential of compounded pharmaceuticals from complex drug pharmacies is expected to be adversely affected by the rise in the number of prohibited drugs. In this regard, the U.S. FDA announced that, begin in June 2015, it will add four medications to its list of those that are "not allowed to be compounded" in large quantities by outside institutions. These include acetaminophen, aprotinin (Trasylol), ondansetron hydrochloride (Zofran), and bromocriptine mesylate (Tylenol). The demand for common compounded medications like Tylenol might decrease if an order forbidding the compounding of these medicines is issued.
  • Lack of trained lab workers and pharmacists in developing markets, high maintenance costs for sterile environments, and potential barriers will to some extent hinder market expansion.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Compounding Pharmacy Market size was valued at USD 8.12 billion in 2019 and is poised to grow from USD 8.62 billion in 2023 to USD 14.82 billion by 2031, growing at a CAGR of 6.2% in the forecast period (2024-2031).

The compounding pharmacy market is highly fragmented, with a high level of competition. The prominent players operating in the market such as nature. B. Braun, Athenex Pharma Solutions, Fresenius Kabi, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Lorraine’s Pharmacy, Nephron Pharmaceuticals Corporation To maintain market rivalry, these leading industry firms strategically implement several inorganic growth tactics like mergers and acquisitions. 'B. Braun Melsungen AG', 'Fagron NV', 'PharMEDium Services LLC', 'Fresenius Kabi AG', 'Becton, Dickinson and Company', 'McGuff Compounding Pharmacy Services Inc.', 'Wedgewood Pharmacy', 'Village Compounding Pharmacy', 'Dougherty's Pharmacy, Inc.', 'Institutional Pharmacy Solutions', 'Pencol Compounding Pharmacy', 'Lorraine's Pharmacy', 'Triangle Compounding Pharmacy', 'Custom Med Apothecary', 'The Compounding Center', 'Letco Medical', 'Lee Silsby Compounding Pharmacy', 'Olympia Pharmacy', 'Precision Compounding Pharmacy', 'College Pharmacy'

Increased oral medication use is major opportunities for market expansion.

The market for compounding pharmacies is expected to grow as a result of increased topical formulation research and development. Topical formulations including gels, creams, ointments, and other such products are highly sought-after. Pharmaceutical companies are focusing their efforts on R&D to create ground-breaking topical formulations. These elements are therefore expected to fuel market expansion in the near future.

North America compounding pharmacy market share is expanding at a consistent rate. High disposable income among the people in North America has driven the developments in the healthcare industry due to the affordability to invest in highly advanced medication that meets the targeted medical needs of the people.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Compounding Pharmacy Market

Report ID: SQMIG35I2094

$5,300
BUY NOW GET FREE SAMPLE